Metabolic dysfunction associated fatty liver disease (MAFLD), metabolic dysfunction associated steatotic liver disease (MASLD), metabolic associated steatohepatitis (MASH) and obesity

Best Practice & Research Clinical Gastroenterology · Elsevier

Аннотация

Publication date: Available online 30 June 2026 Source: Best Practice & Research Clinical Gastroenterology Author(s): Davor Štimac

Читать у издателя →

Похожие статьи